HYZAAR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Losartan Potassium; Hydrochlorothiazide.
| Product ID | 0006-0745_32622632-0367-4cc0-ae2e-21b02371dfcb |
| NDC | 0006-0745 |
| Product Type | Human Prescription Drug |
| Proprietary Name | HYZAAR |
| Generic Name | Losartan Potassium And Hydrochlorothiazide |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1995-04-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020387 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE |
| Active Ingredient Strength | 100 mg/1; mg/1 |
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1995-04-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1995-04-28 |
| Marketing Category | NDA |
| Application Number | NDA020387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1995-04-28 |
| Marketing Category | NDA |
| Application Number | NDA020387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1995-04-28 |
| Marketing End Date | 2011-08-29 |
| Marketing Category | NDA |
| Application Number | NDA020387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1995-04-28 |
| Marketing End Date | 2011-08-29 |
| Marketing Category | NDA |
| Application Number | NDA020387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1995-04-28 |
| Marketing End Date | 2011-08-29 |
| Marketing Category | NDA |
| Application Number | NDA020387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1995-04-28 |
| Ingredient | Strength |
|---|---|
| LOSARTAN POTASSIUM | 100 mg/1 |
| SPL SET ID: | d3e434b9-2f56-4dec-8cbf-a61e23abcc6a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-0717 | HYZAAR | losartan potassium and hydrochlorothiazide |
| 0006-0745 | HYZAAR | losartan potassium and hydrochlorothiazide |
| 0006-0747 | HYZAAR | losartan potassium and hydrochlorothiazide |
| 21695-788 | HYZAAR | HYZAAR |
| 43353-926 | HYZAAR | HYZAAR |
| 55289-522 | HYZAAR | HYZAAR |
| 63629-3183 | HYZAAR | HYZAAR |
| 0054-0126 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
| 0054-0127 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
| 0054-0277 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
| 0093-7367 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
| 0093-7368 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
| 0093-7369 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
| 0781-5816 | losartan potassium and hydrochlorothiazide | losartan potassium and hydrochlorothiazide |
| 0781-5817 | losartan potassium and hydrochlorothiazide | losartan potassium and hydrochlorothiazide |
| 0781-5818 | losartan potassium and hydrochlorothiazide | losartan potassium and hydrochlorothiazide |
| 13668-116 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HYZAAR 74431110 1917146 Live/Registered |
MERCK SHARP & DOHME CORP. 1993-09-01 |